These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3257707)

  • 1. Comparative bioavailability and kinetics of folinic acid in the pharmaceutical formulations of Rescuvolin and Ledervorin in healthy volunteers.
    Guelen PJ; Vree TB; de Vos D; Lamers K
    Biopharm Drug Dispos; 1988; 9(1):31-9. PubMed ID: 3257707
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioequivalence of oral and injectable levoleucovorin and leucovorin.
    DeVito JM; Kozloski GD; Tonelli AP; Johnson JB
    Clin Pharm; 1993 Apr; 12(4):293-9. PubMed ID: 8458180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of two leucovorin calcium tablet formulations.
    De Vito JM; McGuire BW; De Lap RJ; Weiss AI
    DICP; 1989 Feb; 23(2):153-4. PubMed ID: 2786292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adults.
    Mehta BM; Gisolfi AL; Hutchison DJ; Nirenberg A; Kellick MG; Rosen G
    Cancer Treat Rep; 1978 Mar; 62(3):345-50. PubMed ID: 306284
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacokinetics of fluorouracil and folinic acid.
    Schalhorn A; Kühl M
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):82-92. PubMed ID: 1557660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients.
    Damle B; Ravandi F; Kaul S; Sonnichsen D; Ferreira I; Brooks D; Stewart D; Alberts D; Pazdur R
    Clin Cancer Res; 2001 Mar; 7(3):517-23. PubMed ID: 11297242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary analysis of a randomized comparison of 5-fluorouracil versus 5-fluorouracil and high-dose continuous-infusion folinic acid in disseminated colorectal cancer.
    Doroshow JH; Bertrand M; Newman E; Multhauf P; Leong L; Blayney D; Goldberg D; Margolin K; Carr B; Akman S
    NCI Monogr; 1987; (5):171-4. PubMed ID: 3501538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma kinetic study following oral administration of leucovorin tablets in patients with gastric cancer--influence of subtotal gastrectomy].
    Nashimoto A; Sasaki J; Akai S; Sato T; Inada S
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3747-54. PubMed ID: 2596859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancer.
    Mader RM; Steger GG; Rizovski B; Sieder AE; Locker G; Gnant MF; Jakesz R; Rainer H
    Br J Clin Pharmacol; 1994 Mar; 37(3):243-8. PubMed ID: 8198932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously.
    Priest DG; Schmitz JC; Bunni MA; Stuart RK
    J Natl Cancer Inst; 1991 Dec; 83(24):1806-12. PubMed ID: 1744924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of (-)-folinic acid after oral and intravenous administration of the racemate.
    Greiner PO; Zittoun J; Marquet J; Cheron JM
    Br J Clin Pharmacol; 1989 Sep; 28(3):289-95. PubMed ID: 2789922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid.
    Schalhorn A; Kühl M; Stupp-Poutot G; Nüssler V
    Cancer Chemother Pharmacol; 1990; 25(6):440-4. PubMed ID: 2311173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of folinic acid and 5-methyltetrahydrofolic metabolite after repeated oral administration of calcium folinate following methotrexate treatment.
    Tubiana-Mathieu N; Monjanel-Mouterde S; Lejeune C; Payet B; Catalin J; Carcassonne Y; Cano J
    Eur J Cancer; 1994; 30A(9):1281-4. PubMed ID: 7999413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability of two brands of ciprofloxacin: an Indian study.
    Suthakaran C; Rajaram S; Adithan C
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):66-8. PubMed ID: 1551749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of tetrahydrofolates in human plasma after leucovorin administration.
    Bunni MA; Rembiesa BM; Priest DG; Sahovic E; Stuart R
    Cancer Chemother Pharmacol; 1989; 23(6):353-7. PubMed ID: 2785439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism of folinic acid (leucovorin) following oral and parenteral administration.
    Taguchi H
    J Nutr Sci Vitaminol (Tokyo); 1981; 27(4):283-90. PubMed ID: 6977022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma kinetic study of folinic acid and 5-methyltetrahydrofolate in healthy volunteers and cancer patients by high-performance liquid chromatography.
    Payet B; Fabre G; Tubiana N; Cano JP
    Cancer Chemother Pharmacol; 1987; 19(4):319-25. PubMed ID: 3496173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminishing bioavailability of oral leucovorin calcium.
    Rossi JG
    Clin Pharm; 1988 Oct; 7(10):721-2. PubMed ID: 3266127
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative bioavailability and pharmacokinetics of three formulations of albuterol.
    Powell ML; Weisberger M; Gural R; Chung M; Patrick JE; Radwanski E; Symchowicz SS
    J Pharm Sci; 1985 Feb; 74(2):217-9. PubMed ID: 3989697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.